Table 1 Demographics and medical data of the ovarian cancer patient cohort (n = 158).
From: CpG-binding protein CFP1 promotes ovarian cancer cell proliferation by regulating BST2 transcription
Parameter | Mean (standard deviation) (range) |
|---|---|
Age | 48.38 (13.53) (17–82) |
Number (%) of patients | |
Pathological type | |
Normal | 4 (2.5) |
Benign tumor | 5 (3.1) |
Serous papillary | 74 (46.8) |
Endometrial | 53 (33.5) |
Mucinous | 31 (19.6) |
Pathological grading | |
I | 48 (30.4) |
II | 40 (25.3) |
III | 66 (41.7) |
T stage | |
T1 | 76 (48.1) |
T2 | 56 (35.4) |
T3 | 26 (16.4) |
N stage | |
N0 | 150 (94.9) |
N1 | 7 (4.5) |
M stage | |
M0 | 135 (85.4) |
M1 | 22 (14.0) |
CFP1 immunohistochemistry score | |
Negative (0) | 38 (24.1) |
+ (1) | 50 (31.6) |
++ (2) | 40 (25.3) |
+++ (3) | 26 (16.4) |
++++ (4) | 9 (5.7) |
